文献速递关节外科

双凸面髌骨假体在262例翻修全膝关节置换中10年耐久性达96%

Biconvex Patellar Components: 96% Durability at 10 Years in 262 Revision Total Knee Arthroplasties.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

单中心回顾1996至2014年262例使用骨水泥双凸面髌骨假体的翻修全膝关节置换,平均随访7年。因无菌性松动免于髌骨假体翻修的10年生存率为96%,KSS从45.4改善至67.7。结论认为该假体治疗明显髌骨骨缺损耐久性优良、并发症风险低。

要点

  • 因无菌性松动免于髌骨假体翻修的10年生存率为96%。
  • 髌骨假体免于任何翻修的10年生存率为87%。
  • KSS均值由术前45.4改善至术后67.7。

核心结论

  • 在262例翻修全膝关节置换队列中,双凸面髌骨假体治疗明显髌骨骨缺损表现出优良耐久性,因无菌性松动免于髌骨再翻修的10年生存率为96%。
  • 该假体可靠,临床结局评分明显改善且并发症风险低。

研究设计与样本

  • 单中心回顾性队列研究,1996至2014年共262例翻修全膝关节置换使用双凸面髌骨假体。
  • 患者翻修时平均年龄69岁,53%为女性,平均随访7年。
  • 评估假体生存率、临床与影像学结果及并发症,证据等级为治疗性Level IV。

主要发现

  • 因无菌性松动免于双凸面髌骨假体翻修的10年生存率为96%。
  • 免于髌骨假体任何翻修的10年生存率为87%,免于任何再翻修和任何再手术的10年生存率分别为75%和70%。
  • KSS均值由指标翻修术前45.4改善至术后67.7,最近影像学残余复合厚度均值为18.1 mm。
  • 除导致翻修的并发症外,最常见并发症为假体周围髌骨骨折(6%,其中3例需翻修)、浅表伤口感染(6%,仅需抗生素治疗或冲洗清创)和关节纤维化(3%)。

关键数值与推荐

  • 因无菌性松动免于髌骨假体翻修的10年生存率为96%。
  • 免于髌骨假体任何翻修的10年生存率为87%。
  • 免于任何再翻修和任何再手术的10年生存率分别为75%和70%。
  • KSS均值由45.4改善至67.7,残余复合厚度均值为18.1 mm。

临床怎么用

  • 对翻修全膝关节置换中明显髌骨骨缺损,可考虑使用骨水泥双凸面髌骨假体以兼顾固定与弥补骨丢失。
  • 术后需关注假体周围髌骨骨折、浅表伤口感染和关节纤维化等并发症。

局限性

  • 为单中心回顾性队列研究,证据等级为治疗性Level IV。
  • 平均随访7年,部分患者未达10年随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal strategy to address osseous deficiencies of the patella during revision total knee arthroplasty (TKA) remains controversial. One possible solution is a cemented biconvex patellar component used such that the non-articular convexity both improves fixation and makes up for bone loss. The aim of this study was to determine the outcomes of the use of biconvex patellar components in a large series of revision TKAs. METHODS: From 1996 to 2014, 262 revision TKAs were performed at a single institution using a biconvex patellar component. Implant survivorship, clinical and radiographic results, and complications were assessed. The mean patient age at the TKA revision was 69 years, and 53% of the patients were female. The mean follow-up was 7 years. RESULTS: The 10-year survivorship free of revision of the biconvex patellar component due to aseptic loosening was 96%. The 10-year survivorship free of any revision of the biconvex patellar component was 87%. The 10-year survivorship free of any rerevision and free of any reoperation was 75% and 70%, respectively. The mean Knee Society Score (KSS) improved from 45.4 before the index revision to 67.7 after it. The mean residual composite thickness seen on the most recent radiographs was 18.1 mm. In addition to the complications leading to revision, the most common complications were periprosthetic patellar fracture (6%), of which 3 required revision; superficial wound infection (6%) requiring antibiotic therapy only or irrigation and debridement; and arthrofibrosis (3%). CONCLUSIONS: In this cohort of 262 revision TKAs, biconvex patellar components used to treat marked patellar bone loss demonstrated excellent durability with a 10-year survivorship free of patellar rerevision due to aseptic loosening of 96%. The biconvex patellar components were reliable as evidenced by substantial improvements in clinical outcomes scores and a low risk of complications. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Hines JT, Lewallen DG, Perry KI, et al. Biconvex Patellar Components: 96% Durability at 10 Years in 262 Revision Total Knee Arthroplasties. J Bone Joint Surg Am. 2021. PMID: 33760782. doi:10.2106/JBJS.20.01064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。